EPIRUBICIN EBEWE epirubicin hydrochloride 100mg/50mL injection Australien - Englisch - Department of Health (Therapeutic Goods Administration)

epirubicin ebewe epirubicin hydrochloride 100mg/50ml injection

sandoz pty ltd - epirubicin hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: sodium chloride; dilute hydrochloric acid; water for injections - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

EPIRUBICIN EBEWE epirubicin hydrochloride 50mg/25mL injection Australien - Englisch - Department of Health (Therapeutic Goods Administration)

epirubicin ebewe epirubicin hydrochloride 50mg/25ml injection

sandoz pty ltd - epirubicin hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; dilute hydrochloric acid; sodium chloride - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

EPIRUBICIN EBEWE epirubicin hydrochloride 10mg/5mL injection Australien - Englisch - Department of Health (Therapeutic Goods Administration)

epirubicin ebewe epirubicin hydrochloride 10mg/5ml injection

sandoz pty ltd - epirubicin hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: water for injections; dilute hydrochloric acid; sodium chloride - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Epirubicin 2 mg/ml Solution for Injection Irland - Englisch - HPRA (Health Products Regulatory Authority)

epirubicin 2 mg/ml solution for injection

actavis group hf - epirubicin hydrochloride - solution for injection - 2 milligram(s)/millilitre - anthracyclines and related substances; epirubicin

EPIRUBICIN HYDROCHLORIDE FOR INJECTION POWDER FOR SOLUTION Kanada - Englisch - Health Canada

epirubicin hydrochloride for injection powder for solution

hospira healthcare ulc - epirubicin hydrochloride - powder for solution - 50mg - epirubicin hydrochloride 50mg - antineoplastic agents

EPIRUBICIN HYDROCHLORIDE INJECTION SOLUTION Kanada - Englisch - Health Canada

epirubicin hydrochloride injection solution

accord healthcare inc - epirubicin hydrochloride - solution - 2mg - epirubicin hydrochloride 2mg - antineoplastic agents